EGFR and colorectal cancer: Our results confirm, in a colorectal cancer model, that SPECT imaging of 111In-F(ab′)2-cetuximab is able to monitor EGFR downregulation and the prevention of tumor growth caused by HSP90 inhibition in vivo.